News on genome-wide association studies, genotyping, metagenomics, basic research in genetics, genomics, and molecular diagnostics.
The score's developers also suggest that current guidelines for stroke prevention may not be sufficient for individuals at higher genomic risk for the condition.
The company released data showing that its panel detects early-stage liver cancer with 71 percent sensitivity compared to 25 percent for the standard test.
This report contains a quantitative, evidence-based scoring framework to help guide the evaluation of constitutional CNVs across clinical labs.
A preliminary analysis lends some support to covering NIPS for pregnancies beyond high-risk, and some payors have expanded coverage.
The German company offers rare disease genetic tests and services for clinical applications, as well as to support drug discovery and development programs.
